Trial with unique way to deliver Docetaxel https://www.sciencedirect.com/science/article/pii/S0168365920303540
This was a phase I dose escalation trial as well. I assume Thera will be monitoring tumour size in each patient after every treatment cycle as well. Which means they should be seeing efficacy data all the way along the trial.
"The total tumour burden measured in this patient decreased from 129 mm at screening to 109 mm in cycle 2, 90 mm in cycle 4, 86 mm in cycle 6 and 85 mm at EOT."